Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 04/10/2020. Reported reason: Delay in shipping of the drug
Shortage Details
- Status
- Current
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-671-50
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50)
- Initial Posting
- 04/10/2020
- Revised Date
Reason
Delay in shipping of the drug